Toward a transdiagnostic tool to evaluate depressive symptoms across mental disorders: validation of the Calgary Depression Rating Scale in patients with major depressive disorder

Jean-Arthur Micoulaud-Franchi, Mélanie Faugere, Sebastien Weibel, Catherine Faget, Christophe Lancon, Raphaëlle Richieri, Michel Cermolacce
Psychiatry Research. 2018-10-01; 268: 68-71
DOI: 10.1016/j.psychres.2018.06.062

PubMed
Lire sur PubMed




1. Psychiatry Res. 2018 Jul 4;268:68-71. doi: 10.1016/j.psychres.2018.06.062.

Toward a transdiagnostic tool to evaluate depressive symptoms across mental disorders: Validation of the Calgary depression rating scale in patients with major depressive disorder.

Micoulaud-Franchi JA(1), Faugere M(2), Weibel S(3), Faget C(2), Lancon C(2), Richieri R(2), Cermolacce M(4).

Author information:
(1)Services d’explorations fonctionnelles du système nerveux, Clinique du sommeil, CHU de Bordeaux, Place Amélie Raba-Leon, 33076 Bordeaux, France; USR CNRS 3413 SANPSY, CHU Pellegrin, Université de Bordeaux, France. Electronic address: *protected email*.
(2)APHM, Hôpital de la Conception, Service de Psychiatrie Universitaire du Professeur Christophe Lançon, 13005, Marseille, France; Aix Marseille Université, Santé Publique: Maladies chroniques et Qualité de Vie, SPMC UPRES EA3279, 13005, Marseille, France.
(3)Department of Psychiatry, University Hospital of Strasbourg, Strasbourg, France; Inserm U1114, Strasbourg France.
(4)Pôle de Psychiatrie « Solaris », Centre Hospitalier Universitaire de Sainte-Marguerite, 270 Bd de Sainte-Marguerite, 13009 Marseille, France;
Laboratoire de Neurosciences Cognitives (LNC), UMR CNRS 7291, 31 Aix-Marseille Université, Site St Charles, 3 place Victor Hugo, 13331 Marseille cedex 3, France.

The severity of depressive symptoms across two discrete mental disorders should be evaluated with the same psychometrically validated tools. In patients with schizophrenia the Calgary Depression Rating Scale (CDSS) is recommended for evaluating depressive symptoms. The aim of this study was to validate the CDSS in patients with major depressive disorder. The CDSS exhibit satisfactory psychometric properties for evaluating depressive symptoms in major depressive disorder. Clinicians and researchers now have a validated scale at their disposal to evaluate depressive symptoms in various mental disorders using a transdiagnostic approach.

Copyright © 2018 Elsevier B.V. All rights reserved.

DOI: 10.1016/j.psychres.2018.06.062
PMID: 30007120


Auteurs Bordeaux Neurocampus